0001213900-23-022878.txt : 20230324
0001213900-23-022878.hdr.sgml : 20230324
20230324180340
ACCESSION NUMBER: 0001213900-23-022878
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230322
FILED AS OF DATE: 20230324
DATE AS OF CHANGE: 20230324
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COLEMAN KIRK ALLEN
CENTRAL INDEX KEY: 0001790624
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39102
FILM NUMBER: 23760998
MAIL ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001733413
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824344737
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: 737-802-1973
MAIL ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
4
1
ownership.xml
X0407
4
2023-03-22
0
0001733413
TFF Pharmaceuticals, Inc.
TFFP
0001790624
COLEMAN KIRK ALLEN
1751 RIVER RUN, SUITE 400
FORT WORTH
TX
76107
0
1
0
0
Chief Financial Officer
0
Stock Options (Right to Buy)
0.80
2023-03-22
4
A
0
100000
0
A
2024-03-22
2033-03-22
Common Stock
100000
100000
D
The Options are granted under TFF Pharmaceuticals, Inc. 2021 Stock Incentive Plan. The Options shall vest and first become exercisable as follows: one-quarter of the Options shall vest and first become exercisable on March 22, 2024 and the remainder of the Options shall vest and first become exercisable in 12 equal quarterly installments commencing on June 22, 2024.
/s/ Kirk Allen Coleman
2023-03-24